Your browser is no longer supported. Please, upgrade your browser.
We’ve released a new Beta version of our Futures section! Try it now. We look forward to your feedback! ×
Abbott Laboratories
IndexS&P 500 P/E40.93 EPS (ttm)1.13 Insider Own0.20% Shs Outstand1.51B Perf Week-1.41%
Market Cap69.79B Forward P/E19.28 EPS next Y2.40 Insider Trans-16.88% Shs Float1.51B Perf Month-1.91%
Income1.72B PEG4.25 EPS next Q0.42 Inst Own69.90% Short Float0.82% Perf Quarter5.77%
Sales20.25B P/S3.45 EPS this Y-10.30% Inst Trans-0.03% Short Ratio2.28 Perf Half Y16.80%
Book/sh14.25 P/B3.25 EPS next Y11.95% ROA6.40% Target Price48.90 Perf Year23.07%
Cash/sh2.96 P/C15.65 EPS next 5Y9.64% ROE11.60% 52W Range36.99 - 47.64 Perf YTD3.80%
Dividend0.96 P/FCF55.57 EPS past 5Y-21.10% ROI6.20% 52W High-2.91% Beta0.67
Dividend %2.08% Quick Ratio1.20 Sales past 5Y-8.00% Gross Margin54.60% 52W Low25.02% ATR0.63
Employees77000 Current Ratio1.40 Sales Q/Q5.50% Oper. Margin13.60% RSI (14)47.11 Volatility1.09% 1.30%
OptionableYes Debt/Eq0.34 EPS Q/Q35.50% Profit Margin13.10% Rel Volume0.78 Prev Close46.52
ShortableYes LT Debt/Eq0.16 EarningsApr 22 BMO Payout51.10% Avg Volume5.43M Price46.25
Recom2.10 SMA20-0.61% SMA50-0.35% SMA2006.11% Volume4,250,822 Change-0.58%
Mar-27-15Reiterated Barclays Equal Weight $48 → $52
Jan-30-15Reiterated Stifel Buy $47 → $49
Jan-30-15Reiterated Barclays Equal Weight $43 → $48
Sep-22-14Reiterated RBC Capital Mkts Outperform $44 → $48
Jul-17-14Reiterated Stifel Buy $42 → $47
Jul-17-14Reiterated Barclays Equal Weight $40 → $43
Mar-10-14Initiated Singular Research Sell $30
Dec-16-13Reiterated Deutsche Bank Hold $37 → $39
Oct-07-13Reiterated Stifel Buy $44 → $40
Jul-18-13Reiterated Barclays Equal Weight $35 → $37
May-28-13Reiterated RBC Capital Mkts Outperform $38 → $42
May-21-13Initiated Gabelli & Co Buy
Apr-19-13Reiterated RBC Capital Mkts Outperform $37 → $38
Apr-18-13Reiterated Stifel Buy $40 → $44
Apr-12-13Reiterated Deutsche Bank Hold $33 → $35
Feb-15-13Initiated Stifel Nicolaus Buy $40
Jan-11-13Reiterated UBS Buy $75 → $38
Jan-11-13Initiated Barclays Equal Weight $35
Jan-04-13Downgrade Deutsche Bank Buy → Hold $70 → $33
Jul-19-12Reiterated UBS Buy $68 → $72
Apr-19-15 10:06AM  Bogus to call budget cuts deep: Deloitte AAP
Apr-16-15 09:20AM  Maverick Capital Eliminates Its Position in AbbVie
12:00AM  Blisters, Dehydration and More: Marathon Medicine Races Ahead
Apr-15-15 06:06PM  Abbott Labs, Sekisui Medical to Offer Coagulation Tests - Analyst Blog
01:45PM  Abbott carves out deeper relationship with Boston Marathon at
09:00AM  New Blood Glucose Meter Provides People with Diabetes an Accurate, Affordable Solution for Glucose Testing-Without Insurance Copays PR Newswire
Apr-14-15 09:00AM  Abbott and Sekisui Collaborate to Offer Coagulation Testing for Laboratories Worldwide PR Newswire
08:00AM  Morning Roundup: Victoria's Secret as the next Abercrombie & Fitch, the Big Give is back, Ohio State is No. 1 in football and basketball at
Apr-13-15 10:00AM  Boston Athletic Association And Abbott Announce Multiple-Year Sponsorship Of The Boston Marathon PR Newswire
Apr-10-15 05:01PM  ABBOTT LABORATORIES Files SEC form 8-K, Change in Directors or Principal Officers
10:55AM  Worried About a Recession? Then Buy These 5 Stocks at Investopedia
Apr-09-15 05:55AM  Options Traders in Abbott Labs Look for Another Quick Buck at TheStreet
05:47AM  Bulls coming back to Abbott Labs
Apr-08-15 06:14PM  Your first trade for Thursday, April 9 at CNBC
05:58PM  Fast Money Final Trade: ABT, DIS, NKE & YHOO
12:25PM  Can Perrigo Get More From Mylan? at 24/7 Wall St.
12:18PM  Mylan's bid for Perrigo leading to a $700 million payday for Abbott Labs at MarketWatch
Apr-07-15 06:06PM  P&G, Visa Make Great Long-Term Investments, Says Edward Jones Strategist at TheStreet
Apr-02-15 09:00AM  First-of-its-Kind Diabetes Technology Revolutionizes How Glucose Data is Collected and Analyzed for People in India PR Newswire
Apr-01-15 07:00PM  Cramer Remix: It's time to buy these oil stocks at CNBC
06:12PM  Cramer: Watch out! Market's No.1 enemy right now at CNBC
12:10PM  Does the Mylan Secondary Make Its Stock Cheap? at 24/7 Wall St.
10:41AM  Mylan (MYL) Stock Is Down Today After Pricing Secondary Offering at TheStreet
09:00AM  Abbott Hosts Conference Call for First-Quarter Earnings PR Newswire
07:47AM  Early movers: SHLD, WMT, GDDY, AAPL & more at CNBC
Mar-31-15 07:48PM  Mylan N.V. Announces Pricing of Secondary Public Offering of a Portion of Abbott's Ordinary Shares at noodls
04:50PM  The Future of Big Pharma Stocks at Investopedia
04:06PM  Pfizers Global Vaccines, Oncology & Consumer Healthcare Segment
Mar-30-15 06:55PM  Looking For Top Management? Consider These 3 Big Caps at Investor's Business Daily
04:23PM  Mylan Finds Support After Abbott Labs Offering Tumble at Investor's Business Daily
09:59AM  Mylan (MYL) Stock Falls After Announcing Secondary Offering at TheStreet
09:55AM  Durham's acne drug developer raises $50M, partly from Jim Goodnight at
08:16AM  Abbott Labs Files to Sell Nearly a Third of Its Mylan Stake at The Wall Street Journal
07:12AM  Mylan N.V. Announces Commencement of Secondary Public Offering of a Portion of Abbott's Ordinary Shares at noodls
Mar-29-15 06:00PM  Teva Is on the Prowl and Its Stock Investors Are Taking Notice
Mar-28-15 05:00PM  Teva Is on the Prowl and Its Stock Investors Are Taking Notice at Bloomberg
Mar-26-15 05:47PM  Potential billion-dollar verdict rests on disputed deadline
05:15PM  Billion-dollar verdict rests on disputed missed deadline
04:28PM  MedTech M&As Continue Regardless of Tax Scenarios - Industry Outlook
Mar-24-15 05:00PM  Buyback blackout
Mar-23-15 04:01PM  Pioneering Bay Area med device entrepreneur dies in Thailand accident at
Mar-20-15 11:06AM  Viking Global Exited Its Position in AbbVie
Mar-17-15 02:06PM  Sucampo Pharmaceuticals Revamp Impresses Wall Street at Investor's Business Daily
12:45PM  Pharma Stock Outlook: Let's Make a Deal - Zacks Analyst Interviews
12:45PM  Pharma Stock Outlook: Let's Make a Deal - Industry Outlook
11:35AM  Kentucky joins lawsuit against Omnicare, claiming billions in losses at
Mar-16-15 12:56PM  Top 2nd-half trades: Disney & health care
Mar-15-15 02:00PM  Abbott's MitraClip® System Shown to Mend Hearts and Improve Lives in People in the United States PR Newswire
Mar-13-15 05:06PM  Why investor flows in high-grade bond funds rose Market Realist
11:59AM  This Health Care Dividend Stock Will Take Advantage of Emerging Market Growth at TheStreet
08:59AM  Eminence Capital Sells Position in Allergan
Mar-12-15 07:05PM  High-grade corporate bonds hit highest issuance Market Realist
Mar-11-15 04:43PM  Sale Rumor, Drugs Launch Boost High-Rated Mylan Stock at Investor's Business Daily
03:07PM  Rising U.S. Dollar Could Help Federal Reserve Delay Rate Hike at TheStreet
12:58PM  FMHR Final Trade: C, PNC, TTWO & ABT
Mar-10-15 09:49AM  ABBOTT LABORATORIES Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Mar-06-15 05:05PM  Paulson & Co. adds to its position in Mylan
07:00AM  Complexities of Eye Care Drive Strong Moats at Morningstar
Mar-05-15 06:57PM  Bored by Golf and Cancer Cured, AbbVie CEO Came Back to Work Bloomberg
06:42PM  Bored by Golf and Cured of Cancer, AbbVie CEO Came Back for More at Bloomberg
05:51PM  AbbVie, Pharmacyclics: A Winning $21 Billion Deal at
11:41AM  Abbott Laboratories -- Moody's assigns A2 to Abbott Labs' new senior unsecured notes; stable outlook at Moody's
11:12AM  Paulson & Co. eliminates position in AbbVie Market Realist
Mar-04-15 11:16PM  Abbvie To Pay $21 Billion For Cancer Biotech Pharmacyclics at Forbes
01:24PM  Abbott Laboratories -- Moody's downgrades Abbott Lab's debt rating to A2 from A1; outlook stable at Moody's
Mar-03-15 02:36PM  US STOCKS-Wall St falls from latest records after soft auto sales Reuters
11:42AM  US STOCKS-Wall St falls from latest records; auto sales soft Reuters
09:58AM  US STOCKS-Wall St slips from latest records; Nasdaq below 5,000 Reuters
09:20AM  Mylan Beats on Q4 Earnings, 2015 Guidance Encouraging - Analyst Blog Zacks
09:10AM  US STOCKS-Wall St to dip at open after latest records, Nasdaq 5,000 Reuters
07:24AM  Mylan (MYL) Earnings Report: Q4 2014 Conference Call Transcript at TheStreet
Mar-02-15 07:23PM  Mylan still on the prowl for deals, perhaps one by end 2015 Reuters
06:05PM  Elliott Management starts new position in Cubist Pharmaceuticals Market Realist
05:56PM  Mylan tops 4Q profit forecasts before move overseas AP
05:14PM  Mylan Q4 Earnings, Guidance In Line As Growth Ramps at Investor's Business Daily
04:29PM  Drugmaker Mylan's 4th-qtr profit rises on strong demand in N. America Reuters
Feb-27-15 05:05PM  Mylan inversion deal completed at
04:15PM  Interested In Pharmaceutical Stocks? Try Novartis (ADR) at Investopedia
01:30PM  Will Mylan (MYL) Beat Earnings on New Product Launches? - Analyst Blog Zacks
01:22PM  ABBOTT LABORATORIES Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Financial Statements and EDGAR Online
01:03PM  ABBOTT LABORATORIES Files SEC form 10-K, Annual Report EDGAR Online
12:30PM  Mylan Completes Acquisition Of Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business PR Newswire
07:00AM  Compelling Financial Benefit in Valeant's Latest Buy Morningstar
Feb-25-15 08:16AM  Allergan: A new position for Glenview Capital Management Market Realist
Feb-23-15 01:57PM  3 Companies That Could Be Negatively Impacted By Johnson & Johnson Sale Of Cordis Benzinga
Feb-20-15 05:39PM  Three Top Stocks Break Out As Market Stages Reversal at Investor's Business Daily
10:36AM  Abbott Declares 365th Consecutive Quarterly Dividend PR Newswire
Feb-19-15 10:45PM  Billionaire Bill Ackmans Top Picks: Allergan Inc. (AGN), Air Products & Chemicals Inc. (APD), Canadian Pacific Railway Limited (USA) (CP) at Insider Monkey
07:25PM  How to Build a Better Network at the Office at The Wall Street Journal
09:00AM  Abbott to Present at Cowen and Company 35th Annual Health Care Conference PR Newswire
Feb-18-15 08:43AM  Time to Take Another Look at Oculus Innovative Sciences Company Spotlight
Feb-11-15 03:28PM  Zoetis Profit Up 20%, 2015 Outlook Cut Slightly at The Wall Street Journal
10:56AM  Zoetis Beats on Q4 Earnings, Provides In-Line 2015 Outlook - Analyst Blog Zacks
Feb-10-15 03:02PM  Mylan Faces Patent Infringement Lawsuit for Nexavar - Analyst Blog Zacks
11:19AM  Why Pfizer is Worth $40 at
Feb-09-15 02:31PM  Pfizer's Hospira Acquisition Good for Its Stock But What About Its Bonds? at
Feb-07-15 12:01AM  AbbVie: Big Pharma at a Discount Price at
Feb-04-15 09:00AM  Abbott to Present at Leerink Global Healthcare Conference PR Newswire
Feb-03-15 04:35PM  Mylan to Buy Famy Care Businesses, Boost Women's Health - Analyst Blog Zacks
04:01PM  Insulet Extends Exclusive Agreement for Blood Glucose Monitoring Marketwired
Abbott Laboratories manufactures and sells health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome; intrahepatic cholestasis or depressive symptoms; gynecological disorders; dyslipidemia; hypertension; hypothyroidism; pain, fever, and inflammation; hormone replacement therapy; anti-infective and influenza vaccines; and product that regulates physiological rhythm of the colon. The company's Diagnostic Products segment provides diagnostic systems and tests, such as immunoassay and clinical chemistry systems; assays for screening and diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, and physiological and infectious diseases; hematology systems and reagents; genomic-based tests; informatics and automation solutions; and diagnostic systems and tests for blood analysis, as well as instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents. Its Nutritional Products segment offers pediatric and adult nutritional products, such as prepared infant and follow-on formula. The company's Vascular Products segment provides coronary, endovascular, vessel closure, and structural heart devices to treat vascular diseases. Abbott Laboratories also offers blood, continuous, and flash glucose monitoring systems, including test strips, sensors, data management decision software, and accessories for people with diabetes under the FreeStyle brand; and medical devices for the eye, including cataract surgery, LASIK surgery, contact lens care products, and dry eye products. The company serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies. It has strategic alliance with Fonterra. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Contreras JaimeSenior Vice PresidentMar 31Sale46.4322810,5862,094Apr 02 05:03 PM
White J. ScottSenior Vice PresidentMar 26Option Exercise22.4918,600418,364108,202Mar 27 05:10 PM
White J. ScottSenior Vice PresidentMar 26Sale46.6812,483582,66395,719Mar 27 05:10 PM
Warmuth Michael JExecutive Vice PresidentMar 10Sale46.4113,500626,58149,433Mar 12 05:32 PM
Contreras JaimeSenior Vice PresidentMar 02Sale47.349,209435,95436,898Mar 03 05:20 PM
Pavee Jean-YvesSenior Vice PresidentMar 02Sale47.4865230,95825,606Mar 03 05:07 PM
Contreras JaimeSenior Vice PresidentFeb 18Sale46.2642319,5681,379Feb 18 05:49 PM
Simhambhatla Murthy VSenior Vice PresidentFeb 17Sale46.411727,98345,199Feb 19 05:11 PM
ALLEN HUBERT LExecutive Vice PresidentFeb 17Sale46.381727,97851,941Feb 19 05:12 PM
Pavee Jean-YvesSenior Vice PresidentFeb 17Sale46.4162128,82122,912Feb 18 06:45 PM
Funck Robert EVice President, ControllerFeb 13Option Exercise22.2710,542234,73973,468Feb 17 05:55 PM
CAPEK JOHN MExecutive Vice PresidentFeb 04Option Exercise25.2583,0002,095,426309,945Feb 06 05:11 PM
CAPEK JOHN MExecutive Vice PresidentFeb 04Sale45.7638,7731,774,430236,880Feb 06 05:11 PM
CAPEK JOHN MExecutive Vice PresidentFeb 04Sale45.839,935455,340226,945Feb 06 05:12 PM
CAPEK JOHN MExecutive Vice PresidentFeb 04Sale45.6634,2921,565,612275,653Feb 06 05:11 PM
Contreras JaimeSenior Vice PresidentNov 25Option Exercise26.4651,6001,365,50481,736Nov 26 05:06 PM
Contreras JaimeSenior Vice PresidentNov 25Sale44.0751,6002,274,08030,136Nov 26 05:06 PM
WHITE MILES DChairman and CEOOct 29Option Exercise22.2738,034846,9031,452,559Oct 30 06:04 PM
WHITE MILES DChairman and CEOOct 29Sale42.7038,0341,624,0521,414,525Oct 30 06:04 PM
WHITE MILES DChairman and CEOOct 28Option Exercise22.27402,7668,968,3911,817,291Oct 30 06:04 PM
WHITE MILES DChairman and CEOOct 28Sale42.50402,76617,117,6341,414,525Oct 30 06:04 PM
Fussell Stephen RExecutive Vice PresidentSep 18Option Exercise22.7931,900726,872141,664Sep 19 05:10 PM
FREYMAN THOMAS CExecutive Vice PresidentJul 21Option Exercise24.0779,0001,901,828390,326Jul 22 05:03 PM
Landgraf John CExecutive Vice PresidentJun 03Option Exercise31.9118,203580,771113,334Jun 05 05:09 PM